The US Food and Drug Administration (FDA) has granted approval for Amgens’ Kyprolis (carfilzomib) combination therapy to treat patients with relapsed or refractory multiple myeloma.
MediciNova has received rare paediatric disease status from the US Food and Drug Administration (FDA) for its MN-166 (ibudilast)…
Wellstat Therrpeutics has received approval from the US Food and Drug Administration (FDA) for its Vistogard (uridine triacetate) to…
The Federal Court of Australia has ruled that UK-based Reckitt Benckiser’s Nurofen made misleading pain relief claims.
BySwitzerland-based biotech firm Omnio has teamed-up with Canadian pharmaceutical firm ProMetic to develop a new drug for slow-healing chronic…
Baxalta has received marketing approval from the European Commission for its Obizur (Antihaemophilic Factor [ecombinant], Porcine Sequence) to treat…
The US Food and Drug Administration (FDA) has granted approval for Roche's Cotellic (cobimetinib) in combination with Zelboraf (vemurafenib)…
Eisai has signed a worldwide collaboration agreement with Purdue Pharma to develop and commercialise its clinical candidate lemborexant, which…
Boehringer Ingelheim Pharmaceuticals and Eli Lilly have received approval from the US Food and Drug Administration (FDA) for Synjardy…